| Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus G M Ashraf, N H Greig, T A Khan, I Hassan, S Tabrez, S Shakil, I A Sheikh, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 219 | 2014 |
| Neuroprotective role of steroidal sex hormones: an overview AN Siddiqui, N Siddiqui, RA Khan, A Kalam, NR Jabir, MA Kamal, ... CNS neuroscience & therapeutics 22 (5), 342-350, 2016 | 99 | 2016 |
| An overview on the correlation of neurological disorders with cardiovascular disease CK Firoz, NR Jabir, MS Khan, M Mahmoud, S Shakil, GA Damanhouri, ... Saudi journal of biological sciences 22 (1), 19-23, 2015 | 62 | 2015 |
| An overview on the current status of cancer nanomedicines NR Jabir, K Anwar, CK Firoz, M Oves, MA Kamal, S Tabrez Current medical research and opinion 34 (5), 911-921, 2018 | 57 | 2018 |
| Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases NR Jabir, CK Firoz, SS Baeesa, GM Ashraf, S Akhtar, W Kamal, MA Kamal, ... CNS neuroscience & therapeutics 21 (1), 1-7, 2015 | 45 | 2015 |
| Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers CK Firoz, NR Jabir, MA Kamal, MN Alama, GA Damanhouri, W Khan, ... IUBMB life 67 (6), 453-459, 2015 | 38 | 2015 |
| A synopsis of nano-technological approaches toward anti-epilepsy therapy: present and future research implications N R Jabir, S Tabrez, CK Firoz, S Kashif Zaidi, S S Baeesa, S Hua Gan, ... Current drug metabolism 16 (5), 336-345, 2015 | 37 | 2015 |
| Assessment of genetic diversity in IL‐6 and RANTES promoters and their level in Saudi coronary artery disease patients NR Jabir, CK Firoz, MA Kamal, GA Damanhouri, MN Alama, AS Alzahrani, ... Journal of Clinical Laboratory Analysis 31 (5), e22092, 2017 | 35 | 2017 |
| A putative association of interleukin‐10 promoter polymorphisms with cardiovascular disease S Tabrez, M Ali, NR Jabir, CK Firoz, GM Ashraf, S Hindawi, ... Iubmb Life 69 (7), 522-527, 2017 | 34 | 2017 |
| An overview on global trends in nanotechnological approaches for Alzheimer therapy G Md Ashraf, S Tabrez, N R Jabir, CK Firoz, S Ahmad, I Hassan, A Alexiou, ... Current drug metabolism 16 (8), 719-727, 2015 | 32 | 2015 |
| A literature perspective on the pharmacological applications of yohimbine NR Jabir, CK Firoz, TA Zughaibi, MA Alsaadi, AM Abuzenadah, ... Annals of Medicine 54 (1), 2849-2863, 2022 | 29 | 2022 |
| The use of azoles containing natural products in cancer prevention and treatment: An overview NR Jabir, CK Firoz, A Bhushan, S Tabrez, MA Kamal Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 28 | 2018 |
| Reduction in CD16/CD56 and CD16/CD3/CD56 natural killer cells in coronary artery disease NR Jabir, CK Firoz, F Ahmed, MA Kamal, S Hindawi, GA Damanhouri, ... Immunological investigations 46 (5), 526-535, 2017 | 27 | 2017 |
| Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies G Aliev, K Shahida, S Hua Gan, CK Firoz, A Khan, A M Abuzenadah, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 25 | 2014 |
| Assessment of IL‐18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients NR Jabir, CK Firoz, MA Kamal, GA Damanhouri, MN Alama, Q Alam, ... Journal of cellular biochemistry 118 (7), 1849-1854, 2017 | 21 | 2017 |
| Current updates on therapeutic advances in the management of cardiovascular diseases N R Jabir, A Nasir Siddiqui, C Kandy Firoz, G Md Ashraf, S Kashif Zaidi, ... Current Pharmaceutical Design 22 (5), 566-571, 2016 | 21 | 2016 |
| Estimation of Interleukin‐1β Promoter (− 31 C/T and− 511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients S Tabrez, NR Jabir, CK Firoz, S Hindawi, S Shakil, GA Damanhouri, ... Journal of Cellular Biochemistry 118 (9), 2977-2982, 2017 | 19 | 2017 |
| Chemical profile and therapeutic potentials of Xylocarpus moluccensis (Lam.) M. Roem.: A literature-based review MT Islam, J Sharifi-Rad, M Martorell, ES Ali, MN Asghar, F Deeba, ... Journal of ethnopharmacology 259, 112958, 2020 | 18 | 2020 |
| An insight on the pathogenesis and treatment of systemic lupus erythematosus M Ali, CK Firoz, NR Jabir, M Rehan, MS Khan, S Tabrez Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2018 | 16 | 2018 |
| Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients S Banu, N R Jabir, N C Manjunath, CK Firoz, M A Kamal, M S Khan, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 16 | 2014 |
Dr. Shams TabrezProfessor, King Fahd Medical Research Center在 kau.edu.sa 的电子邮件经过验证
